Department Home >
- Base >
- You are here
Spheramine
Primary Study Objective
To determine if implanted encapsulated retinal epithelial cells will improve symptoms of Parkinson's disease in advanced patients.
Study Population
Patients with advanced Parkinson's disease
Principal Investigators
Matthew Stern, MD
Contact Person
Heather Maccarone, RN
Phone (215) 829-7181
